Delivra Health Brands CEO Gord Davey joined Steve Darling from Proactive to discuss the company’s financial and operational performance for the three and six months ended December 31, 2024. Delivra Health’s portfolio, featuring innovative wellness brands Dream Water and LivRelief, continues to address common health concerns such as sleeplessness, chronic pain, and anxiety. Davey highlighted the company’s strong second-quarter results, with sales increasing 34% compared to the same period last year. The company also made significant progress in closing the sales gap relative to Q1 fiscal 2025, reinforcing its upward growth trajectory and positioning it well to achieve its commercial objectives for the year. During the quarter, Delivra Health ramped up its marketing efforts, investing in consumer promotional programs across all channels. This strategy, alongside securing new product listings, expanding its customer base, and launching key growth initiatives, has strengthened its market presence. Looking ahead, the company remains committed to expanding its product portfolio across North America and international markets. By leveraging multiple distribution channels, Delivra Health aims to enhance market penetration and drive long-term shareholder value. #proactiveinveestors #delivrahealthbrandsinc #tsxv #dhb #otcqb #dhbuf #DreamWater #GlobalExpansion #UAE #MiddleEastMarket #SleepAid #HealthAndWellness #PharmacyProducts #RegulatoryCompliance #DubaiWarehouse #ProductLaunch #MarketGrowth #InternationalBusiness #HealthSupplements #LabelTranslation #Pharmaceuticals #ConsumerProducts #GlobalStrategy #HealthBrands #ExpansionNews #invest #investing #investment #investor #stockmarket #stocks #stock #stockmarketnews